APO Research
Talk to an analyst

APO RESEARCH · REPORT

Betahistine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Betahistine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchBetahistine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Betahistine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Betahistine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Betahistine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Betahistine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Betahistine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Takeda Pharmaceutical Company Limited, Mylan, Orion Corporation, Nichi-Iko Pharmaceutical, HENNIG ARZNEIMITTEL GmbH & Co. KG, EA Pharma Co., Ltd., DOC Generici and Disphar International B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Betahistine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Betahistine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Betahistine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Betahistine market size, projected growth trends, production technologies, key applications, and end-use industries.

Betahistine Segment by Company

TOWA PHARMACEUTICAL CO., LTD

Takeda Pharmaceutical Company Limited

Mylan

Orion Corporation

Nichi-Iko Pharmaceutical

HENNIG ARZNEIMITTEL GmbH & Co. KG

EA Pharma Co., Ltd.

DOC Generici

Disphar International B.V.

Ciclum Farma Unipessoal

Betahistine Segment by Type

8mg

25mg

Others

Betahistine Segment by Application

Cerebral Thrombosis

Cerebral Embolism

Others

Betahistine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Betahistine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Betahistine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Betahistine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Betahistine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Betahistine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Betahistine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Betahistine Industry Trends Table 2. Betahistine Industry Drivers Table 3. Betahistine Industry Opportunities and Challenges Table 4. Betahistine Industry Restraints Table 5. Global Betahistine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Betahistine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Betahistine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Betahistine Sales Market Share by Manufacturers Table 9. Global Betahistine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Betahistine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Betahistine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Betahistine Manufacturers, Product Type & Application Table 13. Global Betahistine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Betahistine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 8mg Table 17. Major Manufacturers of 25mg Table 18. Major Manufacturers of Others Table 19. Global Betahistine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Betahistine Sales by Type (2021-2026) & (K Units) Table 21. Global Betahistine Sales by Type (2027-2032) & (K Units) Table 22. Global Betahistine Sales Market Share by Type (2021-2026) Table 23. Global Betahistine Sales Market Share by Type (2027-2032) Table 24. Global Betahistine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Betahistine Revenue by Type (2021-2026) & (K Units) Table 26. Global Betahistine Revenue by Type (2027-2032) & (K Units) Table 27. Global Betahistine Revenue Market Share by Type (2021-2026) Table 28. Global Betahistine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cerebral Thrombosis Table 30. Major Manufacturers of Cerebral Embolism Table 31. Major Manufacturers of Others Table 32. Global Betahistine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Betahistine Sales by Application (2021-2026) & (K Units) Table 34. Global Betahistine Sales by Application (2027-2032) & (K Units) Table 35. Global Betahistine Sales Market Share by Application (2021-2026) Table 36. Global Betahistine Sales Market Share by Application (2027-2032) Table 37. Global Betahistine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Betahistine Revenue by Application (2021-2026) & (K Units) Table 39. Global Betahistine Revenue by Application (2027-2032) & (K Units) Table 40. Global Betahistine Revenue Market Share by Application (2021-2026) Table 41. Global Betahistine Revenue Market Share by Application (2027-2032) Table 42. Global Betahistine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Betahistine Sales by Region (2021-2026) & (K Units) Table 44. Global Betahistine Sales Market Share by Region (2021-2026) Table 45. Global Betahistine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Betahistine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Betahistine Sales by Country (2021-2026) & (K Units) Table 49. North America Betahistine Sales by Country (2027-2032) & (K Units) Table 50. Europe Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Betahistine Sales by Country (2021-2026) & (K Units) Table 52. Europe Betahistine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Betahistine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Betahistine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Betahistine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Betahistine Sales by Country (2027-2032) & (K Units) Table 59. Global Betahistine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Betahistine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Betahistine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Betahistine Revenue Market Share by Region (2021-2026) Table 63. Global Betahistine Revenue Market Share by Region (2027-2032) Table 64. TOWA PHARMACEUTICAL CO., LTD Company Information Table 65. TOWA PHARMACEUTICAL CO., LTD Business Overview Table 66. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio Table 68. TOWA PHARMACEUTICAL CO., LTD Recent Development Table 69. Takeda Pharmaceutical Company Limited Company Information Table 70. Takeda Pharmaceutical Company Limited Business Overview Table 71. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Pharmaceutical Company Limited Betahistine Product Portfolio Table 73. Takeda Pharmaceutical Company Limited Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mylan Betahistine Product Portfolio Table 78. Mylan Recent Development Table 79. Orion Corporation Company Information Table 80. Orion Corporation Business Overview Table 81. Orion Corporation Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Orion Corporation Betahistine Product Portfolio Table 83. Orion Corporation Recent Development Table 84. Nichi-Iko Pharmaceutical Company Information Table 85. Nichi-Iko Pharmaceutical Business Overview Table 86. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Nichi-Iko Pharmaceutical Betahistine Product Portfolio Table 88. Nichi-Iko Pharmaceutical Recent Development Table 89. HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information Table 90. HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview Table 91. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio Table 93. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development Table 94. EA Pharma Co., Ltd. Company Information Table 95. EA Pharma Co., Ltd. Business Overview Table 96. EA Pharma Co., Ltd. Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. EA Pharma Co., Ltd. Betahistine Product Portfolio Table 98. EA Pharma Co., Ltd. Recent Development Table 99. DOC Generici Company Information Table 100. DOC Generici Business Overview Table 101. DOC Generici Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. DOC Generici Betahistine Product Portfolio Table 103. DOC Generici Recent Development Table 104. Disphar International B.V. Company Information Table 105. Disphar International B.V. Business Overview Table 106. Disphar International B.V. Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Disphar International B.V. Betahistine Product Portfolio Table 108. Disphar International B.V. Recent Development Table 109. Ciclum Farma Unipessoal Company Information Table 110. Ciclum Farma Unipessoal Business Overview Table 111. Ciclum Farma Unipessoal Betahistine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Ciclum Farma Unipessoal Betahistine Product Portfolio Table 113. Ciclum Farma Unipessoal Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Betahistine Distributors List Table 117. Betahistine Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Betahistine Product Image Figure 2. Global Betahistine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Betahistine Market Size (2021-2032) & (US$ Million) Figure 4. Global Betahistine Sales (2021-2032) & (K Units) Figure 5. Global Betahistine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Betahistine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 8mg Image Figure 9. 25mg Image Figure 10. Others Image Figure 11. Global Betahistine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Betahistine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Betahistine Sales Market Share by Type (2021-2032) Figure 14. Global Betahistine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Betahistine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Betahistine Revenue Market Share by Type (2021-2032) Figure 17. Cerebral Thrombosis Image Figure 18. Cerebral Embolism Image Figure 19. Others Image Figure 20. Global Betahistine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Betahistine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Betahistine Sales Market Share by Application (2021-2032) Figure 23. Global Betahistine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Betahistine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Betahistine Revenue Market Share by Application (2021-2032) Figure 26. North America Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Betahistine Sales Market Share by Country (2021-2032) Figure 28. U.S. Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Betahistine Sales Market Share by Country (2021-2032) Figure 33. Germany Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Betahistine Sales Market Share by Country (2021-2032) Figure 40. China Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Betahistine Sales Market Share by Country (2021-2032) Figure 48. Brazil Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Betahistine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Betahistine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Betahistine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Betahistine Revenue (2021-2032) & (US$ Million) Figure 59. North America Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Betahistine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Betahistine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Betahistine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Betahistine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Betahistine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg
  • 25mg
  • Others
Applications
  • Cerebral Thrombosis
  • Cerebral Embolism
  • Others
Companies covered
  • TOWA PHARMACEUTICAL CO., LTD
  • Takeda Pharmaceutical Company Limited
  • Mylan
  • Orion Corporation
  • Nichi-Iko Pharmaceutical
  • HENNIG ARZNEIMITTEL GmbH & Co. KG
  • EA Pharma Co., Ltd.
  • DOC Generici
  • Disphar International B.V.
  • Ciclum Farma Unipessoal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Betahistine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Betahistine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Betahistine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Betahistine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Betahistine Market Dynamics
  1. 2.1 Betahistine Industry Trends
  2. 2.2 Betahistine Industry Drivers
  3. 2.3 Betahistine Industry Opportunities and Challenges
  4. 2.4 Betahistine Industry Restraints
3 Betahistine Market by Manufacturers
  1. 3.1 Global Betahistine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Betahistine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Betahistine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Betahistine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Betahistine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Betahistine Manufacturers, Product Type & Application
  7. 3.7 Global Betahistine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Betahistine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Betahistine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Betahistine Tier 1, Tier 2, and Tier 3
4 Betahistine Market by Type
  1. 4.1 Betahistine Type Introduction
  2. 4.1.1 8mg
  3. 4.1.2 25mg
  4. 4.1.3 Others
  5. 4.2 Global Betahistine Sales by Type
  6. 4.2.1 Global Betahistine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Betahistine Sales by Type (2021-2032)
  8. 4.2.3 Global Betahistine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Betahistine Revenue by Type
  10. 4.3.1 Global Betahistine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Betahistine Revenue by Type (2021-2032)
  12. 4.3.3 Global Betahistine Revenue Market Share by Type (2021-2032)
5 Betahistine Market by Application
  1. 5.1 Betahistine Application Introduction
  2. 5.1.1 Cerebral Thrombosis
  3. 5.1.2 Cerebral Embolism
  4. 5.1.3 Others
  5. 5.2 Global Betahistine Sales by Application
  6. 5.2.1 Global Betahistine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Betahistine Sales by Application (2021-2032)
  8. 5.2.3 Global Betahistine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Betahistine Revenue by Application
  10. 5.3.1 Global Betahistine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Betahistine Revenue by Application (2021-2032)
  12. 5.3.3 Global Betahistine Revenue Market Share by Application (2021-2032)
6 Global Betahistine Sales by Region
  1. 6.1 Global Betahistine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Betahistine Sales by Region (2021-2032)
  3. 6.2.1 Global Betahistine Sales by Region (2021-2026)
  4. 6.2.2 Global Betahistine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Betahistine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Betahistine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Betahistine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Betahistine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Betahistine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Betahistine Revenue by Region
  1. 7.1 Global Betahistine Revenue by Region
  2. 7.1.1 Global Betahistine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Betahistine Revenue by Region (2021-2026)
  4. 7.1.3 Global Betahistine Revenue by Region (2027-2032)
  5. 7.1.4 Global Betahistine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Betahistine Revenue (2021-2032)
  8. 7.2.2 North America Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Betahistine Revenue (2021-2032)
  11. 7.3.2 Europe Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Betahistine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Betahistine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Betahistine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 TOWA PHARMACEUTICAL CO., LTD
  2. 8.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
  3. 8.1.2 TOWA PHARMACEUTICAL CO., LTD Business Overview
  4. 8.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio
  6. 8.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments
  7. 8.2 Takeda Pharmaceutical Company Limited
  8. 8.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 8.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 8.2.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Company Limited Betahistine Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Betahistine Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Orion Corporation
  20. 8.4.1 Orion Corporation Company Information
  21. 8.4.2 Orion Corporation Business Overview
  22. 8.4.3 Orion Corporation Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Orion Corporation Betahistine Product Portfolio
  24. 8.4.5 Orion Corporation Recent Developments
  25. 8.5 Nichi-Iko Pharmaceutical
  26. 8.5.1 Nichi-Iko Pharmaceutical Company Information
  27. 8.5.2 Nichi-Iko Pharmaceutical Business Overview
  28. 8.5.3 Nichi-Iko Pharmaceutical Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nichi-Iko Pharmaceutical Betahistine Product Portfolio
  30. 8.5.5 Nichi-Iko Pharmaceutical Recent Developments
  31. 8.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
  32. 8.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
  33. 8.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview
  34. 8.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio
  36. 8.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
  37. 8.7 EA Pharma Co., Ltd.
  38. 8.7.1 EA Pharma Co., Ltd. Company Information
  39. 8.7.2 EA Pharma Co., Ltd. Business Overview
  40. 8.7.3 EA Pharma Co., Ltd. Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EA Pharma Co., Ltd. Betahistine Product Portfolio
  42. 8.7.5 EA Pharma Co., Ltd. Recent Developments
  43. 8.8 DOC Generici
  44. 8.8.1 DOC Generici Company Information
  45. 8.8.2 DOC Generici Business Overview
  46. 8.8.3 DOC Generici Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DOC Generici Betahistine Product Portfolio
  48. 8.8.5 DOC Generici Recent Developments
  49. 8.9 Disphar International B.V.
  50. 8.9.1 Disphar International B.V. Company Information
  51. 8.9.2 Disphar International B.V. Business Overview
  52. 8.9.3 Disphar International B.V. Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Disphar International B.V. Betahistine Product Portfolio
  54. 8.9.5 Disphar International B.V. Recent Developments
  55. 8.10 Ciclum Farma Unipessoal
  56. 8.10.1 Ciclum Farma Unipessoal Company Information
  57. 8.10.2 Ciclum Farma Unipessoal Business Overview
  58. 8.10.3 Ciclum Farma Unipessoal Betahistine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ciclum Farma Unipessoal Betahistine Product Portfolio
  60. 8.10.5 Ciclum Farma Unipessoal Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Betahistine Value Chain Analysis
  2. 9.1.1 Betahistine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Betahistine Production Mode & Process
  6. 9.2 Betahistine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Betahistine Distributors
  9. 9.2.3 Betahistine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst